• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃博拉病毒将 IRF3 隔离在病毒包含体中,以逃避宿主抗病毒免疫。

Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity.

机构信息

Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, China.

Institute of Physical Science and Information Technology, Anhui University, Hefei, China.

出版信息

Elife. 2024 Jan 29;12:RP88122. doi: 10.7554/eLife.88122.

DOI:10.7554/eLife.88122
PMID:38285487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10945704/
Abstract

Viral inclusion bodies (IBs) commonly form during the replication of Ebola virus (EBOV) in infected cells, but their role in viral immune evasion has rarely been explored. Here, we found that interferon regulatory factor 3 (IRF3), but not TANK-binding kinase 1 (TBK1) or IκB kinase epsilon (IKKε), was recruited and sequestered in viral IBs when the cells were infected by EBOV transcription- and replication-competent virus-like particles (trVLPs). Nucleoprotein/virion protein 35 (VP35)-induced IBs formation was critical for IRF3 recruitment and sequestration, probably through interaction with STING. Consequently, the association of TBK1 and IRF3, which plays a vital role in type I interferon (IFN-I) induction, was blocked by EBOV trVLPs infection. Additionally, IRF3 phosphorylation and nuclear translocation induced by Sendai virus or poly(I:C) stimulation were suppressed by EBOV trVLPs. Furthermore, downregulation of STING significantly attenuated VP35-induced IRF3 accumulation in IBs. Coexpression of the viral proteins by which IB-like structures formed was much more potent in antagonizing IFN-I than expression of the IFN-I antagonist VP35 alone. These results suggested a novel immune evasion mechanism by which EBOV evades host innate immunity.

摘要

病毒包含体(IBs)在感染细胞中埃博拉病毒(EBOV)复制过程中通常形成,但它们在病毒免疫逃避中的作用很少被探索。在这里,我们发现干扰素调节因子 3(IRF3),而不是 TANK 结合激酶 1(TBK1)或 IκB 激酶 epsilon(IKKε),在细胞被 EBOV 转录和复制有效病毒样颗粒(trVLPs)感染时被募集并隔离在病毒 IBs 中。核蛋白/病毒蛋白 35(VP35)诱导的 IBs 形成对于 IRF3 的募集和隔离至关重要,可能通过与 STING 相互作用。因此,TBK1 和 IRF3 的结合,在 I 型干扰素(IFN-I)诱导中起着至关重要的作用,被 EBOV trVLPs 感染所阻断。此外,EBOV trVLPs 抑制了仙台病毒或 poly(I:C)刺激诱导的 IRF3 磷酸化和核转位。此外,STING 的下调显著减弱了 VP35 诱导的 IRF3 在 IBs 中的积累。形成类似 IBs 的病毒蛋白的共表达比单独表达 IFN-I 拮抗剂 VP35 更能拮抗 IFN-I。这些结果表明了 EBOV 逃避宿主先天免疫的一种新的免疫逃避机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/80712eecf556/elife-88122-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/d1cabce8b00b/elife-88122-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/c457f81463fc/elife-88122-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/0abb9b0bda6f/elife-88122-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/75efee7e61b4/elife-88122-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/f2d8e56cc30a/elife-88122-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/f67f7209c685/elife-88122-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/9a8558e9dedc/elife-88122-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/3a05e42407fd/elife-88122-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/750bc7056599/elife-88122-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/00fbfa613187/elife-88122-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/17d1929ea12b/elife-88122-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/2ed781708d46/elife-88122-fig7-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/80712eecf556/elife-88122-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/d1cabce8b00b/elife-88122-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/c457f81463fc/elife-88122-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/0abb9b0bda6f/elife-88122-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/75efee7e61b4/elife-88122-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/f2d8e56cc30a/elife-88122-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/f67f7209c685/elife-88122-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/9a8558e9dedc/elife-88122-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/3a05e42407fd/elife-88122-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/750bc7056599/elife-88122-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/00fbfa613187/elife-88122-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/17d1929ea12b/elife-88122-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/2ed781708d46/elife-88122-fig7-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af27/10945704/80712eecf556/elife-88122-fig8.jpg

相似文献

1
Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity.埃博拉病毒将 IRF3 隔离在病毒包含体中,以逃避宿主抗病毒免疫。
Elife. 2024 Jan 29;12:RP88122. doi: 10.7554/eLife.88122.
2
Ebola Virus Inclusion Body Formation and RNA Synthesis Are Controlled by a Novel Domain of Nucleoprotein Interacting with VP35.埃博拉病毒包含体的形成和 RNA 合成受核蛋白与 VP35 相互作用的新结构域控制。
J Virol. 2020 Jul 30;94(16). doi: 10.1128/JVI.02100-19.
3
Evasion of antiviral immunity through sequestering of TBK1/IKKε/IRF3 into viral inclusion bodies.通过将 TBK1/IKKε/IRF3 隔离到病毒包含体中来逃避抗病毒免疫。
J Virol. 2014 Mar;88(6):3067-76. doi: 10.1128/JVI.03510-13. Epub 2013 Dec 11.
4
Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.猛犸病毒蛋白对人类和蝙蝠固有免疫途径的影响。
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.00191-20.
5
Evasion of interferon responses by Ebola and Marburg viruses.埃博拉和马尔堡病毒对干扰素反应的逃避。
J Interferon Cytokine Res. 2009 Sep;29(9):511-20. doi: 10.1089/jir.2009.0076.
6
Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells.洛维乌病毒VP24和VP35蛋白在人类和蝙蝠细胞中作为先天性免疫拮抗剂发挥作用。
Virology. 2015 Nov;485:145-52. doi: 10.1016/j.virol.2015.07.010. Epub 2015 Aug 6.
7
Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replication.埃博拉病毒 VP35 扰乱 I 型干扰素信号转导以促进病毒复制。
Virol Sin. 2023 Dec;38(6):922-930. doi: 10.1016/j.virs.2023.10.004. Epub 2023 Oct 13.
8
Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.深入了解埃博拉病毒VP35和VP24的干扰素抑制功能及其作为药物靶点的初步开发
Infect Disord Drug Targets. 2019;19(4):362-374. doi: 10.2174/1871526519666181123145540.
9
Herpes Simplex Virus 1 Serine Protease VP24 Blocks the DNA-Sensing Signal Pathway by Abrogating Activation of Interferon Regulatory Factor 3.单纯疱疹病毒1型丝氨酸蛋白酶VP24通过消除干扰素调节因子3的激活来阻断DNA感应信号通路。
J Virol. 2016 May 27;90(12):5824-5829. doi: 10.1128/JVI.00186-16. Print 2016 Jun 15.
10
Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein.从感染的非人类灵长类动物的淋巴组织转录分析揭示了编码突变 VP35 蛋白的埃博拉病毒减毒和免疫原性的基础。
J Virol. 2021 Feb 24;95(6). doi: 10.1128/JVI.01995-20.

引用本文的文献

1
Participation of host cell proteins in inclusion bodies of non-segmented RNA virus infected cells: a molecular insight.宿主细胞蛋白参与非节段RNA病毒感染细胞的包涵体形成:分子层面的见解
Virol J. 2025 Aug 18;22(1):282. doi: 10.1186/s12985-025-02784-w.
2
Grass carp Trim47 restricts GCRV infection via SPRY domain-mediated autophagic degradation of nonstructural proteins and disruption of viral inclusion bodies.草鱼Trim47通过SPRY结构域介导的非结构蛋白自噬降解和病毒包涵体破坏来限制草鱼呼肠孤病毒感染。
Front Immunol. 2025 Jul 10;16:1623014. doi: 10.3389/fimmu.2025.1623014. eCollection 2025.
3
Long-term clinical sequelae among Sudan ebolavirus disease survivors 2 years post-infection: a matched cohort study.

本文引用的文献

1
Ubiquitination of Ebola virus VP35 at lysine 309 regulates viral transcription and assembly.泛素化埃博拉病毒 VP35 在赖氨酸 309 处调节病毒转录和组装。
PLoS Pathog. 2022 May 9;18(5):e1010532. doi: 10.1371/journal.ppat.1010532. eCollection 2022 May.
2
Ebola virus VP35 hijacks the PKA-CREB1 pathway for replication and pathogenesis by AKIP1 association.埃博拉病毒 VP35 通过与 AKIP1 结合劫持 PKA-CREB1 通路从而实现复制和发病机制。
Nat Commun. 2022 Apr 26;13(1):2256. doi: 10.1038/s41467-022-29948-4.
3
Mechanisms of Immune Evasion by Ebola Virus.
苏丹埃博拉病毒病幸存者感染后2年的长期临床后遗症:一项匹配队列研究。
BMC Med. 2025 Jul 18;23(1):432. doi: 10.1186/s12916-025-04271-z.
4
Antiviral defense against filovirus infections: targets and evasion mechanisms.针对丝状病毒感染的抗病毒防御:靶点与逃逸机制
Future Microbiol. 2025 May-Jun;20(7-9):573-587. doi: 10.1080/17460913.2025.2501924. Epub 2025 May 7.
5
Severe long-term clinical sequelae among Sudan ebolavirus disease survivors 2 years post-infection.苏丹埃博拉病毒病幸存者感染两年后的严重长期临床后遗症
Res Sq. 2025 Apr 17:rs.3.rs-6325522. doi: 10.21203/rs.3.rs-6325522/v1.
6
Genomic transfers help to decipher the ancient evolution of filoviruses and interactions with vertebrate hosts.基因组转移有助于破译丝状病毒的古老进化和与脊椎动物宿主的相互作用。
PLoS Pathog. 2024 Sep 3;20(9):e1011864. doi: 10.1371/journal.ppat.1011864. eCollection 2024 Sep.
7
Negative and ambisense RNA virus ribonucleocapsids: more than protective armor.负义及双义 RNA 病毒核糖核蛋白:不只是保护铠甲。
Microbiol Mol Biol Rev. 2023 Dec 20;87(4):e0008223. doi: 10.1128/mmbr.00082-23. Epub 2023 Sep 26.
埃博拉病毒的免疫逃逸机制。
Adv Exp Med Biol. 2021;1313:15-22. doi: 10.1007/978-3-030-67452-6_2.
4
Nonstructural Protein of Severe Fever with Thrombocytopenia Syndrome Phlebovirus Inhibits TBK1 to Evade Interferon-Mediated Response.发热伴血小板减少综合征布尼亚病毒非结构蛋白抑制 TBK1 逃避干扰素介导的反应。
J Microbiol Biotechnol. 2021 Feb 28;31(2):226-232. doi: 10.4014/jmb.2008.08048.
5
Ebola virus replication is regulated by the phosphorylation of viral protein VP35.埃博拉病毒的复制受病毒蛋白 VP35 磷酸化的调节。
Biochem Biophys Res Commun. 2020 Jan 15;521(3):687-692. doi: 10.1016/j.bbrc.2019.10.147. Epub 2019 Nov 4.
6
Suppression of the IFN-α and -β Induction through Sequestering IRF7 into Viral Inclusion Bodies by Nonstructural Protein NSs in Severe Fever with Thrombocytopenia Syndrome Bunyavirus Infection.严重发热伴血小板减少综合征布尼亚病毒感染通过非结构蛋白 NSs 将 IRF7 隔离到病毒包含体内来抑制 IFN-α 和 -β 的诱导。
J Immunol. 2019 Feb 1;202(3):841-856. doi: 10.4049/jimmunol.1800576. Epub 2018 Dec 31.
7
Ebolaviruses: New roles for old proteins.埃博拉病毒:老蛋白的新角色。
PLoS Negl Trop Dis. 2018 May 3;12(5):e0006349. doi: 10.1371/journal.pntd.0006349. eCollection 2018 May.
8
The Role of Exosomal VP40 in Ebola Virus Disease.外泌体VP40在埃博拉病毒病中的作用
DNA Cell Biol. 2017 Apr;36(4):243-248. doi: 10.1089/dna.2017.3639. Epub 2017 Feb 8.
9
A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus.一种快速筛查检测法确定,单用β干扰素以及核苷类似物联合疗法是埃博拉病毒的有效抑制剂。
PLoS Negl Trop Dis. 2016 Jan 11;10(1):e0004364. doi: 10.1371/journal.pntd.0004364. eCollection 2016 Jan.
10
Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus.丝状病毒发病机制与免疫逃逸:来自埃博拉病毒和马尔堡病毒的见解
Nat Rev Microbiol. 2015 Nov;13(11):663-76. doi: 10.1038/nrmicro3524. Epub 2015 Oct 6.